Lung Cancer Considered | Escuchar podcast en línea gratis

399 episodios

Treating Advanced Thymic Cancers
04/08/2026 | 59 min
Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined by Dr. Nicolas Girard and Dr. Erica Pietroluongo to discuss the diagnosis, staging, and treatment of thymoma and thymic carcinoma, including current standards of care, evolving systemic therapies, and promising areas of research. They also highlight the importance of international collaboration in advancing care for patients with these rare malignancies.

Guests:

Nicolas Girard, MD, PhD
Head of the Thorax Institute Curie Montsouris,
Institut Curie, Paris, France

Erica Pietroluongo, MD, PhD
Medical Oncologist, University Federico II, Naples
Visiting Scholar, University of Chicago
FDA Approval: Zidesamtinib and ROS1 NSCLC
28/07/2026 | 24 min
Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephen Liu, Dr. Alexander Drilon, and Dr. Rosario Charo Garcia Campelo discuss the ARROS1 trial results, the drug's efficacy and safety profile, CNS activity, and where zidesamtinib may fit into current and future treatment strategies for ROS1-positive lung cancer.

Guests:

Alexander Drilon, MD
Chief, Early Drug Development Service
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell Medical College

Rosario Charo Garcia Campelo, MD
Head of Medical Oncology and Thoracic Tumor Unit, Chair, University Hospital
Head of the Oncology Research Group, Biomedical Research Institute A Coruna Spain
Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer
21/07/2026 | 47 min
How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology.
Key Topics Covered:
• ALK-positive lung cancer
• Cellular Therapy
• Vaccines

Guests:

Vincent Lam, MD
Associate Professor of Oncology, Johns Hopkins University School of Medicine
Director, Thoracic Oncology Clinical Research Program
Sidney Kimmel Comprehensive Cancer Center

Carmen Mecca. PhD
Postdoctoral Fellow, Chiarle Lab
Department of Pathology
Boston Children’s Hospital
IASLC - Your First Faculty Job
07/07/2026 | 41 min
Starting your first faculty position can be both exciting and overwhelming. In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Arthi Sridhar to discuss the transition from fellowship to independent practice, sharing practical insights on navigating clinical responsibilities, building professional relationships, balancing personal and professional priorities, and developing a sustainable career in oncology. Whether you're beginning a career in academic or community practice, this conversation offers actionable advice to help you thrive in your early years as faculty.

Guests:

Arthi Sridhar, MD - Arthi.Sridhar@UTSouthwestern.edu
Assistant Professor, Department of Internal Medicine
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered
23/06/2026 | 45 min
In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped modern lung cancer care.

Guest:
Balazs Halmos, MD, MS
Professor of Medicine
Associate Director, Clinical Science
Montefiore Einstein Comprehensive Cancer Center

Más podcasts de Ciencias

Podcasts a la moda de Ciencias

Acerca de Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Sitio web del podcast

Ciencias

Escucha Lung Cancer Considered, Date Un Vlog Oficial y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

Añadir radios y podcasts a favoritos
Transmisión por Wi-Fi y Bluetooth
Carplay & Android Auto compatible
Muchas otras funciones de la app

Abrir app

Descarga la app gratuita: radio.net

Añadir radios y podcasts a favoritos
Transmisión por Wi-Fi y Bluetooth
Carplay & Android Auto compatible
Muchas otras funciones de la app

Lung Cancer Considered

Escanea el código,
Descarga la app,
Escucha.

Lung Cancer Considered: Podcasts del grupo